abagovomab 24
abciximab 24
abituzumab 21
abrilumab 13
actoxumab 11
adalimumab 15
aducanumab 10
afasevikumab 11
alacizumab_pegol 8
alemtuzumab 22
alirocumab 15
amatuximab 29
andecaliximab 20
anifrolumab 14
anrukinzumab 17
aprutumab 16
aprutumab_ixadotin 16
arcitumomab 16
ascrinvacumab 4
atezolizumab 14
atinumab 14
avelumab 9
basiliximab 21
bavituximab 23
begelomab 19
benralizumab 20
bevacizumab_beta 18
bezlotoxumab 11
bimagrumab 10
bleselumab 9
blinatumomab 23
blosozumab 28
bococizumab 16
brazikumab 18
brentuximab_vedotin 19
briakinumab 19
brodalumab 7
brolucizumab 26
brontictuzumab 22
burosumab 14
cabiralizumab 21
camrelizumab 13
canakinumab 22
cantuzumab_ravtansin 31
carlumab 13
carotuximab 13
cergutuzumab_amunaleukin2 24
cergutuzumab_amunaleukin 24
certolizumab_pegol 24
cetiximab 31
citatuzumab_bogatox 25
cixutumumab 16
clivatuzumab_tetraxetan 14
codrituzumab 21
conatumumab 10
concizumab 18
crenezumab 16
crizanlizumab 22
crotedumab 19
dacetuzumab 21
daclizumab 10
dalotuzumab 26
dapirolizumab_pegol 20
daratumumab 12
dectrekumab 10
demcizumab 20
denosumab 8
depatuxizumab 18
depatuxizumab_mafodotin 18
dezamizumab 17
dinutuximab 30
diridavumab 18
domagrozumab 16
drozitumab 12
duligotuzumab 20
durvalumab 8
dusigitumab 12
efalizumab 33
efungumab 21
eldelumab 14
elezanumab 14
elgemtumab 9
elotuzumab 13
emactuzumab 15
emapalumab 21
emibetuzumab 13
enavatuzumab 23
enfortumab_vedotin 13
enoblituzumab 17
enokizumab 25
enoticumab 18
ensituximab 20
eptinezumab 13
erenumab 16
etaracizumab 14
etrolizumab 22
evinacumab 20
evolocumab 11
farletuzumab 3
fasinumab 16
fezakinumab 14
fibatuzumab 9
ficlatuzumab 19
firivumab 24
flanvotumab 14
fletikumab 14
foralumab 13
foravirumab 15
fremanezumab 29
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 11
ganitumab 19
gantenerumab 9
gemetuzumab 20
gemtuzumab2 18
gemtuzumab 16
gevokizumab 21
girentuximab 20
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 19
ibalizumab 26
ibritumomab 16
icrucumab 11
idarucizumab 22
ifabotuzumab 9
imalumab 15
imgatuzumab 17
inclacumab 20
indatuximab_ravtansin 23
indusatumab 13
inebilizumab 19
intetumumab 6
iodine_girentuximab 28
ipilimumab 3
iratumumab 5
isatuximab 23
itolizumab 22
ixekizumab 23
labetuzumab_govitecan 18
lambrolizumab 23
lampalizumab 21
lanadelumab 18
landogrozumab 15
laprituximab 22
lebrikizumab 23
lendalizumab 22
lenzilumab 15
lifastuzumab_vedotin 24
ligelizumab 23
lilotomab 24
lirilumab 20
lodelcizumab 15
lokivetmab 16
lorvotuzumab_mertansin 17
lucatumumab 29
lumretuzumab 16
lupartumab 15
lutikizumab 15
margetuximab 30
milatuzumab 26
mirvetuximab 25
mirvetuximab_soravtansin 25
modotuximab 35
mogamulizumab 22
monalizumab 17
motavizumab 23
moxetumomab_pasudotox 19
namilumab 18
naratuximab 23
naratuximab_emtansin 23
narnatumab 15
navicixizumab2 25
navicixizumab 22
navivumab 29
necitumumab 10
nemolizumab 19
nesvacumab 14
nivolumab 12
obiltoxaximab 18
obinutuzumab 30
ocaratuzumab 19
ofatumumab 14
olaratumab 14
olokizumab 23
omalizumab 17
onartuzumab 21
ontuxizumab 15
opicinumab 13
orticumab 11
otelixizumab 35
oxelumab 10
ozanezumab 22
pamrevlumab 11
panobacumab 18
parsatuzumab 24
pasotuxizumab 17
pateclizumab 12
patritumab 11
pembrolizumab 23
perakizumab 21
pidilizumab 13
pinatuzumab_vedotin 16
plozalizumab 23
pogalizumab 17
polatuzumab_vedotin 20
ponezumab 25
prezalumab 14
pritoxaximab 28
quilizumab 19
racotumomab 25
radretumab 13
ralpancizumab 21
ramucirumab 11
ranevetmab 23
ranibizumab 18
refanezumab 19
remtolumab 17
rilotumumab 14
rinucumab 14
risankizumab 29
rituximab 14
rivabazumab 21
robatumumab 20
roledumab 28
romosozumab 17
rontalizumab 15
rosmantuzumab 20
rozanolixizumab 18
sacituzumab 24
sacituzumab_govitecan 24
samalizumab 20
sapelizumab 21
sarilumab 17
secukinumab 11
seribantumab 15
setoxaximab 30
sifalimumab 9
siltuximab 17
simtuzumab 20
sirukumab 9
solanezumab 26
solitomab 17
stamulumab 15
suptavumab 22
suvizumab 14
tabalumab 11
tadocizumab 10
tamtuvetmab 27
tanezumab 18
tarextumab 11
tavolixizumab 12
telisotuzumab 19
teplizumab 12
tesidolumab 19
tezepelumab 22
tigatuzumab 14
tildrakizumab 19
timolumab 13
tisotumab 11
tosatoxumab 26
tositumomab 13
tralokinumab 21
trastuzumab 24
tregalizumab 21
trevogrumab 11
ublituximab 16
urelumab 14
ustekinumab 25
utomilumab 21
vadastuximab 18
vadastuximab_talirin 18
vandortuzumab_vedotin 16
vantictumab 16
vanucizumab2 18
vanucizumab 24
varlilumab 16
vatelizumab 17
vedolizumab 21
veltuzumab 7
vesencumab 9
vorsetuzumab 19
vorsetuzumab_mafodotin 19
vunakizumab 26
xentuzumab 17
zatuximab 35
